BPC-157 could potentially be used perioperatively to accelerate healing of intestinal anastomoses, skin grafts and surgical wounds
Another key role of B12, along with folic acid, is helping to turn homocysteine into methionine
Protocol 4: nasal spray approach Goal: Needle-free administration with acceptable bioavailability trade-off Duration: 20 days active, then 4-6 months off Schedule: Days 1-20: 10-15 mg epitalon intranasally, divided into 2-3 daily doses Days 21-180: Off cycle Repeat 1-2 times per year Formulation: Reconstitute in saline with 3 percent DMSO for improved nasal absorption
Chemical class Small-molecule quinolinium compound Peptide status Not a peptide Primary research target Nicotinamide N-methyltransferase Common abbreviation 5A1MQ or 5-AMQ Evidence level Cell and animal research Human trials No controlled human trial identified UK approval No marketing authorisation identified Main evidence warning Mouse outcomes do not establish human results What Is 5-Amino-1MQ
People with Wilson's disease or copper metabolism disorders should avoid copper peptides entirely
Published human evidence for BPC-157 remains trivial